Carisma Therapeutics Inc. Files 8-K, Details Name Changes
Ticker: CARM · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1485003
Sentiment: neutral
Topics: corporate-information, name-change
TL;DR
Carisma Therapeutics (formerly Sesen Bio, formerly Eleven Biotherapeutics) filed an 8-K on Jan 13, 2025.
AI Summary
On January 13, 2025, Carisma Therapeutics Inc. filed an 8-K report. The filing indicates a change in the company's former name from Sesen Bio, Inc. on May 16, 2018, and previously from Eleven Biotherapeutics, Inc. on February 23, 2010. The company is incorporated in Delaware and its principal executive offices are located at 3675 Market Street, Suite 401, Philadelphia, PA 19104.
Why It Matters
This filing provides historical context on the company's identity evolution, which can be important for understanding its corporate structure and past operations.
Risk Assessment
Risk Level: low — The filing is primarily informational, detailing historical company name changes and corporate information without disclosing new material financial or operational events.
Key Players & Entities
- Carisma Therapeutics Inc. (company) — Registrant
- Sesen Bio, Inc. (company) — Former Company Name
- Eleven Biotherapeutics, Inc. (company) — Former Company Name
- January 13, 2025 (date) — Date of Report
- May 16, 2018 (date) — Date of Name Change
- February 23, 2010 (date) — Date of Name Change
- 3675 Market Street, Suite 401, Philadelphia, PA 19104 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Carisma Therapeutics Inc.?
The primary purpose of this 8-K filing is to report current information as required by the SEC, specifically detailing the company's corporate information and historical name changes.
When was Carisma Therapeutics Inc. formerly known as Sesen Bio, Inc.?
Carisma Therapeutics Inc. was formerly known as Sesen Bio, Inc. as of May 16, 2018.
What was the company's name before it was Eleven Biotherapeutics, Inc.?
The filing does not state a name prior to Eleven Biotherapeutics, Inc.; it indicates that Eleven Biotherapeutics, Inc. changed its name on February 23, 2010.
In which state is Carisma Therapeutics Inc. incorporated?
Carisma Therapeutics Inc. is incorporated in Delaware.
What is the address of Carisma Therapeutics Inc.'s principal executive offices?
The address of Carisma Therapeutics Inc.'s principal executive offices is 3675 Market Street, Suite 401, Philadelphia, PA 19104.
Filing Stats: 972 words · 4 min read · ~3 pages · Grade level 16.1 · Accepted 2025-01-13 07:00:21
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CARM The Nasdaq Stock Mar
Filing Documents
- tm253058d1_8k.htm (8-K) — 28KB
- 0001104659-25-002839.txt ( ) — 199KB
- carm-20250113.xsd (EX-101.SCH) — 3KB
- carm-20250113_lab.xml (EX-101.LAB) — 33KB
- carm-20250113_pre.xml (EX-101.PRE) — 22KB
- tm253058d1_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARISMA THERAPEUTICS INC. By: /s/ Steven Kelly Date: January 13, 2025 Steven Kelly President and Chief Executive Officer